From "How To Buy A Stock?" to Technical Analysis Training, we provide Complete Training:
Learn The Ropes
Engage In Our Community
Become an Expert
What Our Clients Say
– Dave Lindahl | RE Mentor, IncWhat I am most impressed with is the cleverness, yet simplicity that Alan’s system is built upon. It is written for the average person, The Blue Collar Investor.
– John and Beronica R. | Allen, TXMy wife and I recently purchased both of your books. They are clearly written and the examples are easy to understand as we have learned a lot of new information.
– Danielle H | Valparaiso, INThe thing I like the most about Alan’s covered call plan is that if you do enough research on the stock at the outset, you can feel comfortable owning it even if it goes down.
– Steve SorensenI want to thank you also for the incredibly good lists and articles that you and your team are putting together. I have learned so much from reading your articles and studying the weekly lists that I am feeling far more confident that I can invest much more wisely.
Recent Blog Posts | Visit The Blog (Weekly Training Articles & Commentary)
Combining Dividend Capture with Covered Call Writing: Pros and Cons
Why not use covered call writing with only dividend-bearing stocks to generate three income streams; option premium, share appreciation to the (out-of-the-money) call strike plus the dividend itself? This article will explore the pros and cons of this approach to covered call writing. Strategy theory We screen for stocks that have ex-dividend dates (also […]
Ask Alan 147 – “Why is the Ellman Calculator Showing Negative Returns?”
Alan answers a question posed by Duminda, who asks: I am trying to understand why I am getting a negative ROO on a trade I made with the ETF BOTZ. First, I bought 100 shares for $27.13 and sold the February $27.00 in-the-money strike for $0.75. The option expired worthless and I then sold the […]
The Mysteries of a Put Sale
On 8/19/2017, Ron sent me an email detailing a cash-secured put trade he initiated in a virtual account. I saved the email to use in an article because I felt it would be instructive on several fronts. Ron’s trade with Abiomed, Inc. (NASDAQ: ABMD) 8/10/2017: Sell August 17 $155.00 put (sale price not […]
